Concentrations of apoprotein A in whole serum, and cholesterol and phospholipids concentrations in the high-density lipoprotein fraction of serum were measured after the precipitation of low-density and very-low-density lipoproteins with sodium phosphotungstate-Mg2 in 23 patients with liver cirrhosis, 19 
enzymic methods
Since the last century it has been well known that liver diseases are associated with serum lipid disturbances.
In recent years there has been a considerable increase in knowledge concerning the metabolism of lipoproteins in hepatic disease. Attention has mainly been focused on the changes in the high-density lipoproteins (HDL),3 and on the role played by the enzymes lecithin:cholesterol acyltransferase (LCAT; EC 2.3.1.43) and lipoprotein lipase (EC 3.1.1.34) in the transformation of the subfraction HDL1 to HDL2 and HDL3 (1) (2) (3) (4) (5) 
Materials and Methods

Subjects.
The patients were 42 men with liver diseases, 19
at ages 54-67 years (mean ± SD, 60 *.,,5) with extrahepatic biliary obstruction, and 23 at ages 43-67 years (56 ± 7) with liver cirrhosis. Diagnosis was based on clinical data, laboratory tests, endoscopic retrograde cholangiography, laparotomy findings, and percutaneous liver biopsies. Controls were 20 healthy men matched for age with the patients. Blood samples, taken the morning after an overnight fast, were kept cool on ice; serum was separated at 4 #{176}C. Sera in which LCAT activity was to be measured were immediately frozen and kept at -16 #{176}C. Aliquots of the same sera were stored at 4 #{176}C for no more than five days.
Procedures.
Serum cholesterol and serum phospholipids were determined by bnzymic methods with reagents supplied in kit form by Carlo-Erba, Milan, Italy, and Wako Pure Chemical Ltd., Osaka, Japan, respectively. HDL-cholesterol and HDL-phospholipids were measured by the same methods after precipitation of LDL and VLDL by sodium phosphotungstate-Mg2 (9) . Serum ape A was estimated by single radial immunodiffusion (M-Partigen Apo A; Behringwerke AG, Marburg, F.R.G.). Ape A and apoprotein B (apo B) (M-Partigen Apo B) were estimated in the supernate after LDL and VLDL were precipitated as described above. Serum LCAT activity was estimated after delipoproteinization by the simplified method described by Alcindor 
Results
Results of determinations of serum ape A, cholesterol, and phospholipids, and HDL-cholesterol and HDL-phospholipids are shown in Table 1 . The correlation between concentrations of HDL-cholesterol (x) and HDL-phospholipid (y) was positive in control subjects (y = 182.4 + 0.50x, r = 0.62, p <0.005) and in patients with cholestasis (y = 170.8 + 1.04x, r = 0.47, p <0.05); there was no significant correlation in patients with liver cirrhosis (y = 278.7 + 0.73x, r = 0.38). Apo B was not detected in the supernatant fraction in patients or in controls. The concentration of apo A in the supernatant fraction from controls and patients was >90% of that detected in whole serum. A good positive correlation between HDL-cholesterol (x) and ape A (y) concentrations was observed in patients with cirrhosis (y = 594.6 + 0.21x, r = 0.95, p <0.001), and to a lesser degree in patients with cholestasis (y = 288.9 + 2.41x, r = 0.57, p <0.05). Serum LCAT activity (mean ± SD) was 43.3 ± 17.6, 20.7 ± 12.1, and 16.9 ± 13.6 zmol/L per hour, respectively, in control subjects, patients with cholestasis, and patients with cirrhosis; the difference between both groups of patients and the controls were significant (p <0.001). Lecithin/lysolecithin ratios obtained by chromatographic fractionation of phospholipids in whole serum and in the supernatant fraction after precipitation are shown in Table 2 .
DiscussIon
The HDL-cholesterol concentrations (afterprecipitation of LDL and VLDL) inthe serum ofpatientswith liverdisease were much lessthan we observed in patientswith atheromatosis (12) (13) (14) . The clinical implications of thisforvascular risk are not yet known. Concentrations of apo A in serum are de- extrahepatic biliary obstruction agree with these previous studies. The positive correlation of decreased concentrations of ape A and HDL-cholesterol, the absence of apo B in the supernatant fractions, and the similarity of apo A concentrations in the supernates and in the whole serum specimens strongly suggests that the HDL fraction obtained after precipitation with sodium phosphotungstate-Mg2 in patients with liver disease contains proportions of apo A and cholesterol similar to those found in healthy subjects.
In the present study we confirm that in healthy subjects the correlation is good between cholesterol and phospholipids in the HDL fraction after precipitation of lipoproteins rich in apo B, as recently described by others (6) (7) (8) . In addition, we found that HDL-phospholipids were not significantly decreased in patients with cholestasis and were slightly increased in patients with liver cirrhosis, showing that the phospholipid content of nonprecipitable HDL in patients with liver disease is approximately double what should be expected according its apo A and cholesterol content.
The finding of low serum LCAT activity in patients with liver disease is in agreement with previous studies (17) (18) (19) (20) (21) , and probably accounts forthe increased lecithin/lysolecithin ratio in our patients (20) . Apparently, the differencein lecithin/ lysolecithin ratio between subject groups is similar, whether based on examination of whole sera or nonprecipitableHDL.
Furthermore, the lecithin/lysolecithin ratioin nonprecipitable HDL is less than in whole serum. This suggests that changes in LCAT activity may be more apparent in the HDL fraction than in whole serum. 
